BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Achillion Pharmaceuticals, Inc. 

300 George Street

New Haven  Connecticut  06511  U.S.A.
Phone: 203-624-7000 Fax: 203-624-7003


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical

Segment
Drug Discovery





 Company News
Why Gilead Sciences, Inc. (GILD) And AbbVie (ABBV) Are Keeping An Eye On Achillion Pharmaceuticals, Inc. (ACHN) 12/12/2014 6:15:51 AM
Achillion Pharmaceuticals, Inc. (ACHN) To Present At Two Upcoming Investor Conferences 11/25/2014 2:04:04 PM
Achillion Pharmaceuticals, Inc. (ACHN) Reports 100% SVR12 In A Phase 2 Combination Study With ACH-3102 At The Liver Meeting 2014 (American Association for Study of Liver Diseases) 11/10/2014 7:22:23 AM
Achillion Pharmaceuticals, Inc. (ACHN) Announces Upcoming Poster Presentations Discussing Novel Oral Complement Factor D Inhibitor Platform At The 56th Annual Meeting Of The American Society of Hematology 11/6/2014 10:41:08 AM
Achillion Pharmaceuticals, Inc. (ACHN) Reports Third Quarter And Nine Month 2014 Financial Results 11/4/2014 8:20:42 AM
Achillion Pharmaceuticals, Inc. (ACHN) To Present Updated Clinical HCV Data On ACH-3102 And Preclinical Profile Of ACH-3422 At The American Association for Study of Liver Diseases Annual Meeting 10/8/2014 1:01:51 PM
Achillion Pharmaceuticals, Inc. (ACHN) Hits One Year High After Rumors Gilead Sciences, Inc. (GILD) Might Buy It Out 8/27/2014 6:27:16 AM
Achillion Pharmaceuticals, Inc. (ACHN) Granted U.S. Patent For ACH-3102 And Structurally Related NS5A Inhibitors 8/20/2014 7:39:16 AM
Gilead Sciences, Inc. (GILD) Shaky As Achillion Pharmaceuticals, Inc. (ACHN)'s Hepatitis C Drug Cures All Patients In Mid-Stage Trial 8/15/2014 7:12:05 AM
Achillion Pharmaceuticals, Inc. (ACHN) Reports Second Quarter And Six Month 2014 Financial Results 8/8/2014 10:40:29 AM
12345678910...